在21世纪,在β-thalassemia major中成功进行化
Christina Fragodimitri1, Vasiliki Schiza1, Anastasios Giakoumis2
1Thalassemia Unit, "Aghia Sofia" Children's Hospital, Athens, Greece.
Medicine
|October 13, 2023
概括
在beta-thalassemia主要管理方面的进展显著改善了铁负荷. 由心脏和肝脏铁含量定义的化成功率从6%增加到51%,降低死亡率. 这凸显了加强化和MRI监测的必要性.
科学领域:
- 血液学 血液学 血液学
- 心脏病学 心脏病学
- 放射学 放射学是一门学科.
背景情况:
- 贝塔thalassemia主要管理已经显著发展.
- 铁过载是影响心脏和肝脏健康的主要并发症.
- 有效的化疗法对于改善患者的治疗结果至关重要.
研究的目的:
- 分析β-thalassemia主要管理方面的进步带来的好处.
- 为了评估费里丁,心脏T2 *和肝脏铁度的变化.
- 评估实现心脏和肝脏联合铁清除的可行性.
主要方法:
- 在12年的时间里 (2016年) 对209名患者进行了回顾性分析.
- 评价费里丁,心脏T2 *和肝脏铁度 (LIC),独立于化疗法.
- 化成功的评估 (ChS) 被定义为没有心脏铁和可接受的肝脏铁.
- 对接受德费里奥克萨 (A组) 和德费里奥克萨-德费里 (B组) 的患者进行亚组分析.
- 与较早时期的死亡率数据进行比较.
主要成果:
- 总体上,所有患者的CHS从6%增加到51% (P < .0001).
- 在A组中,在8年内,ChS从21%增加到46% (P = .006).
- 在B组,ChS在7年内从0%增加到60% (P<.001).
- 与较早时期相比,观察到死亡率显著下降.
结论:
- 可实现心脏和肝脏铁 (ChS) 的联合清除.
- 对于所有β-thalassemia重症患者来说,ChS应该是新的目标.
- 连续磁共振成像和强化化对于实现ChS至关重要.
更多相关视频
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.5K
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.7K
相关概念视频
Complexation Equilibria: The Chelate Effect
525
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
525
Phase II Reactions: Miscellaneous Conjugation Reactions
64
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
64
EDTA: Chemistry and Properties
2.0K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
2.0K
Extraction: Advanced Methods
466
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
466
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
